Derio, December 2023 – In a significant advancement in the field of liver disease research, OWL Metabolomics, a leader in metabolic process analysis, has joined forces with the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health at Virginia Commonwealth University (VCU).
This collaboration is a testament to the commitment of both institutions to enhance the understanding and treatment of liver diseases.
Reflecting on this momentous partnership, Arun Sanyal, M.D., director of the Virginia Commonwealth University’s Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, stated, “We are excited by to work with OWL Metabolomics as a provider of technologies, as it shares our commitment to move forward diagnostic research discoveries to patients and to transform lives by revolutionizing liver care”.
Adding to the sentiment, Toni Felís, Manager of OWL Metabolomics, said, “Becoming the exclusive metabolomics provider for the Institut Stravitz-Sanyal and working in tandem with both teams is not only an honour but also the foundation of what we anticipate being a long, enduring, and mutually beneficial relationship in diverse scientific research areas.”
The agreement is designed to harness the distinct strengths and expertise of each organization. The Stravitz-Sanyal Institute is globally recognized for its liver disease research, while OWL Metabolomics excels in metabolomic analysis using cutting-edge UPLC-MS technology.
This collaboration will facilitate joint research initiatives and, the sharing of knowledge, data, and resources between the teams. It aims to bring forward significant breakthroughs in liver disease research, combining the scientific acumen of both institutions.